Debiopharm Innovation Fund

Debiopharm is a Swiss biopharmaceutical firm specializing in oncology and bacterial infections. It in-licenses high-potential compounds, conducts clinical development, and out-licenses to pharma partners for global patient access.

Funding Stage: Pre-Seed / Seed, Series A/B

Investor type: VC Firm

Investment Areas: Venture Capital, Health Care, Consulting, Professional Services, Pharmaceutical Manufacturing

Country: Switzerland